KilnFree Tile Startup Dekiln Partners with Johnson Tiles for Pilot Project Offering Potential Boost to UK Ceramics Sector SEC Chairman Proposes Revisiting GunJumping Rules to Revitalize IPO Market Rising Costs Drive Surge in MultiJob Workforce Financial Implications and Labor Market Trends SpaceX Postpones Starship Launch Amid Plans for RecordBreaking Stock Market Debut Prediction Market Platforms Face Legal Offensive from Multiple States and Federal Regulators Baird Raises Price Target on RideNow Group Citing Strong SameStore Sales Performance ETOR Q1 2026 Earnings EPS Surges Past Estimates by 234 Revenue Details Remain Undisclosed AXT Inc Q1 2026 Earnings EPS Surprise Beats Estimates as Company Narrows Loss Veru Inc Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline OI Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Slips Permian Basin Royalty Trust PBT Q3 2009 Earnings EPS Misses Estimates by 53 Amid Weak Energy Market PDLB Q4 2025 Earnings EPS Surges Past Estimates Revenue Details Withheld Assertio Holdings ASRT Holds Steady Near Resistance as Consolidation Continues Roadzen Inc Warrants RDZNW Surge Warrants Rally 175 as Support Holds at 023 Karyopharm Therapeutics KPTI Posts Gains Bounces from Support Tests Key Resistance Atomera ATOM Surges Over 31 as Momentum Builds Above Key Support Tripcom TCOM Slides 3 as Market Sentiment Sours on Travel Demand Concerns Spotify and Universal Music Group Strike Landmark AI Licensing Deal for UserGenerated Remixes Phillips Connect Appoints Mark Wallin as President and General Manager South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Disputes Gold and Silver Decline as Precious Metals Retreat from Recent Highs Enhanced Games Donald Trump JrBacked Steroid Olympics Set for Sunday Debut with Broader Product Ambitions Could The Cigna Group CI Be Considered Among Dividend Growth Stocks for a MultiYear Hold Census Data Reveals Large Firms Lead AI Adoption Among US Businesses SNY Q1 2026 Earnings EPS Surpasses Expectations Amidst Limited Revenue Disclosure Propanc Biopharma PPCB Holds Near Support as Slight Decline Signals Caution